Standout Papers

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhot... 2009 2026 2014 2020 1.7k
  1. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial (2014)
    Brent A. Neuschwander‐Tetri, Rohit Loomba et al. The Lancet
  2. Alcoholic Liver Disease (2009)
    Robert S. O’Shea, Srinivasan Dasarathy et al. Hepatology
  3. EASL Clinical Practice Guidelines on nutrition in chronic liver disease (2018)
    Manuela Merli, Annalisa Berzigotti et al. Journal of Hepatology
  4. Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease (2021)
    Arun J. Sanyal, Mark L. Van Natta et al. New England Journal of Medicine
  5. Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study (2009)
    Srinivasan Dasarathy, Jaividhya Dasarathy et al. Journal of Hepatology
  6. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease (2018)
    Mohammad Shadab Siddiqui, Raj Vuppalanchi et al. Clinical Gastroenterology and Hepatology
  7. Sarcopenia from mechanism to diagnosis and treatment in liver disease (2016)
    Srinivasan Dasarathy, Manuela Merli Journal of Hepatology
  8. ESPEN guideline on clinical nutrition in liver disease (2019)
    Mathias Plauth, William Bernal et al. Clinical Nutrition
  9. A multicenter study to define sarcopenia in patients with end‐stage liver disease (2017)
    Elizabeth J. Carey, Jennifer C. Lai et al. Liver Transplantation
  10. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases (2021)
    Jennifer C. Lai, Puneeta Tandon et al. Hepatology
  11. Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease (2019)
    David E. Kleiner, Elizabeth M. Brunt et al. JAMA Network Open
  12. Sarcopenia and frailty in decompensated cirrhosis (2021)
    Puneeta Tandon, Aldo J. Montaño‐Loza et al. Journal of Hepatology
  13. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis (2021)
    Ali Aminian, Abbas Al‐Kurd et al. JAMA
  14. Estimated Burden of Metabolic Dysfunction–Associated Steatotic Liver Disease in US Adults, 2020 to 2050 (2025)
    Phuc Le, Moosa Tatar et al. JAMA Network Open

Immediate Impact

1 by Nobel laureates 161 standout
Sub-graph 1 of 14

Citing Papers

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
2025 Standout
100 intermediate papers

Works of Srinivasan Dasarathy being referenced

Liver transplantation in the patient with physical frailty
2023
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
2021 Standout
and 29 more

Author Peers

Author Last Decade Papers Cites
Srinivasan Dasarathy 9876 6715 5411 235 15.8k
Valério Nobili 11262 3611 2478 283 15.5k
Leon A. Adams 18336 8886 2290 198 22.2k
Mark L. Van Natta 14287 6182 2716 111 18.7k
Manal F. Abdelmalek 12684 5599 2215 204 16.1k
Maurizio Cassader 7247 1874 2711 177 12.7k
Quentin M. Anstee 18861 8645 2927 247 22.8k
Emmanuel Tsochatzis 11637 9154 1278 298 15.1k
Manuel Romero‐Gómez 10745 7741 1360 400 14.3k
Paul Angulo 21596 11575 2780 155 25.9k
Stephen H. Caldwell 14013 10002 1217 256 18.4k

All Works

Loading papers...

Rankless by CCL
2026